Ask AI

Downloadable Slides

Share

Program Content

Activities

  • ADC in R/R DLBCL
    Novel ADC Therapies for Relapsed/Refractory Large B-Cell Lymphoma: Translating the Latest Advances Into Community Oncology Practice
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 02, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from ADC Therapeutics and Pfizer Inc.

ADC Therapeutics

Pfizer, Inc.